Past performance is not an indicator of future performances. And also law of averages.
w/o Afrezza, diabetes causes lots of medical problem, and hypos. Hypos brings a lot of business to the Hospitals. Problems in organs due to high sugar level brings in a lot of business in the pharmaceutical and Medical communities. Those in turn brings about the need for FDA's existence. That is why most of the people are against the success of Afrezza. Heck even the patients want it to fail (e.g., Amy T) because they do not want to lose their jobs due to economic downturn which the success of Afrezza will bring about.
All the other medicines, even though seemingly improves the condition of the patients, in fact cause more damages in side effects thus keeping the economy going and growing. JMHO
Except that PureTech is in Boston, and all its companies are in MA area, not in Seattle.
That shows that SNY stopped their efforts after April-May time frame.
They can see how many ads SNY put up for Toujeo vs Afrezza. Toujeo was launched later than Afrezza, and yet the ads were aplenty for Toujeo in the TV.